Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: A 9-Week, open-label, randomized, crossover, noninferiority study

Clinical Therapeutics

Volumn 33, Issue 8, 2011, Pages 1069-1076

  Wolthers, Ole D ^a   Walters, Ewan G ^b  

^a Children's Clinic Randers   (Denmark)

^b Teva UK Limited   (United Kingdom)

Author keywords

Adrenal function; Asthma; Beclomethasone dipropionate; Corticosteroids; Growth; Hydroflouroalkane 134a; Knemometry; Lower leg growth; Steroids

Indexed keywords

BECLOMETASONE DIPROPIONATE; CHLOROFLUOROCARBON; CORTISONE; FLUORINATED HYDROCARBON;

ALLERGIC CONJUNCTIVITIS; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; FEVER; GROWTH RATE; HEADACHE; HERPES ZOSTER; HUMAN; HYPERACTIVITY; INFLUENZA; LOWER LEG; MAJOR CLINICAL STUDY; MALE; PERIORBITAL EDEMA; PHARYNGITIS; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; SORE THROAT; URINALYSIS;

ADMINISTRATION, INHALATION; AEROSOL PROPELLANTS; ANTI-ASTHMATIC AGENTS; ASTHMA; BECLOMETHASONE; CHILD; CHILD, PRESCHOOL; CHLOROFLUOROCARBONS; CROSS-OVER STUDIES; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCARBONS, FLUORINATED; HYDROCORTISONE; LEG; MALE; METERED DOSE INHALERS; TREATMENT OUTCOME;

EID: 80051625220     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2011.06.015     Document Type: Article

References (21)

1. Bacharier L.B., Boner A., Carlsen K.H., et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008, 63:5-34. The European Paediatric Asthma Group.
2. Wolthers O.D., Honour J.W. Measures of hypothalamic-pituitary-adrenal function in patients with asthma treated with inhaled glucocorticoids: clinical and research implications. J Asthma 1999, 36:477-486.
3. Wolthers O.D. Systemic activity of inhaled beclomethasone dipropionate hydroflouroalkane-134a in children with asthma. Pediatr Asthma Allergy Immunol 2007, 19:172-179.
4. Brambilla G., Ganderton D., Garzia R., et al. Modulation of aerosol clouds produced by pressurised inhalation aerosols. Int J Pharm 1999, 186:53-63.
5. Ederle K. Improved control of asthma symptoms with a reduced dose of HFA-BDP extrafine aerosol: an open-label, randomised study. Eur Rev Med Pharmacol Sci 2003, 7:45-55. Multicentre Study Group.
6. Szefler S.J., Warner J., Staab D., et al. Switching from conventional to extrafine aerosol beclometasone dipropionate therapy in children: a 6-month, open- label, randomized trial. J Allergy Clin Immunol 2002, 110:45-50.
7. Chan I.S. Proving non-inferiority or equivalence of two treatments with dichotomous endpoints using exact methods. Stat Methods Med Res 2003, 12:37-58.
8. Wolthers O.D. Methodology and implications of knemometry in growth assessment of inhaled glucocorticoids. Pediatr Allergy Immunol 2010, 21:e190-e198.
9. Tanner J.M. The development of the reproductive system. Growth at Adolescence 1962, 28-39. Blackwell Scientific, Oxford. 2nd ed.
10. Declaration of Helsinki-Ethical Principles for Medical Research Involving Human Subjects (Appendix 1) World Medical Association, Accessed June 17, 2011. http://www.wma.net/en/30publications/10policies/b3/.
11. Note for Guidance on Clinical Practice (CPMP/ICH/135/95) International Conference on Harmonisation (ICH) Topic E6 (R1), Accessed June 17, 2011. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002874.pdf.
12. Heuck C., Wolthers O.D. Calculation of knemometric growth rates in group studies of children treated with exogenous glucocorticoids. Ann Hum Biol 1997, 24:411-418.
13. Fink R.S., Pierre L.N., Daley-Yates P.T., et al. Hypothalamic-pituitary-adrenal axis function after inhaled corticosteroids: unreliability of urinary free cortisol estimation. J Clin Endocrinol Metab 2002, 87:4541-4546.
14. Wolthers O.D., Honour J.W. Hypothalamic-pituitary-adrenal function in children with asthma and rhinitis treated with topical glucocorticosteroids. Clin Exp Allergy 1998, 28:545-550.
15. Blackwell Encyclopedia of Sociology Online, Accessed June 17, 2011. http://www.sociologyencyclopedia.com/public/.
16. Guidelines & Resources Global Initiative for Asthma (GINA), Accessed June 17, 2011. http://www.ginasthma.org/Guidelines/guidelines-resources.html.
17. Hermanussen M. The measurement of short term growth. J Pediatr Endocrinol Metab 2003, 16:969-971.
18. Schou A.J., Plomgaard A.M., Thomsen K., Wolthers O.D. Lower leg growth suppression caused by inhaled inhaled glucocorticoids is not accompanied by reduced thickness of cutis or subcutis. Acta Paediatr 2004, 93:623-627.
19. Gradman J., Wolthers O.D. A randomized trial of lower leg and height growth in children with asthma treated with inhaled budesonide from a new dry powder inhaler. Pediatr Allergy Immunol 2010, 21:e206-e212.
20. Woodcock A., Acerbi D., Poli G. Modulite technology: pharmacodynamic and pharmacokinetic implications. Respir Med 2002, 96(Suppl D):S9-S15.
21. Vastagh E., Kuna P., Calistruc P., Bogdan M.A. Efficacy and safety of inhaled budesonide delivered once or twice daily via HFA-134a in mild to moderate persistent asthma in-patients. Comparison with budesonide CFC. Respir Med 2003, 97(Suppl F):S20-S28.